Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy

Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy

Abstract Background Although de novo metastatic breast cancer (dnMBC) is acknowledged as a heterogeneous disease, the current staging systems do not distinguish between patients within the M1 or stage IV category. This study aimed to refine the M1 category and prognostic staging for dnMBC to enhance...

Full description

Bibliographic Details
Main Authors: Lei Ji, Ge Song, Min Xiao, Xi Chen, Qing Li, Jiayu Wang, Ying Fan, Yang Luo, Qiao Li, Shanshan Chen, Fei Ma, Binghe Xu, Pin Zhang
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Thoracic Cancer
Subjects:
de novo metastatic breast cancer
prognosis
staging
surgery
Online Access:https://doi.org/10.1111/1759-7714.15452

Internet

https://doi.org/10.1111/1759-7714.15452

Similar Items